Topics

Abbott’s MitraClip is cost effective, increases life expectancy and improves quality of life

21:37 EDT 1 Oct 2019 | Compelo Medical Devices

Abbott announced new analyses of the landmark COAPTTM Trial that show the company’s MitraClipTM device is cost effective and is projected to increase both life-expectancy and quality of

The post Abbott’s MitraClip is cost effective, increases life expectancy and improves quality of life appeared first on NS Medical Devices.

Original Article: Abbott’s MitraClip is cost effective, increases life expectancy and improves quality of life

NEXT ARTICLE

More From BioPortfolio on "Abbott’s MitraClip is cost effective, increases life expectancy and improves quality of life"

Quick Search

Relevant Topic

Abbott
The 11th largest pharmaceutical company in the world, <!--LGfEGNT2Lhm-->Abbott Laboratories generated sales of $16 billion in 2009 and has 90,000 employees. Within the <!--LGfEGNT2Lhm-->medical device arm of the company, products of note ar...